AMIKACIN News
AMIKACIN currently has 0 news articles, with 27 predicted indications.
This page combines the AI-predicted indications for AMIKACIN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (27):
- bacterial arthritis (99.0%)
- escherichia coli infection (99.0%)
- bacterial pneumonia (99.0%)
- bacterial meningitis caused by gram-negative bacteria (99.0%)
- rhinoscleroma (99.0%)
- pneumonia caused by gram negative bacteria (99.0%)
- Escherichia coli meningitis (99.0%)
- sclerosing cholangitis (99.0%)
- Pseudomonas aeruginosa infectious disease (99.0%)
- suppurative cholangitis (99.0%)
- bacterial meningitis (99.0%)
- viral meningitis (99.0%)
- arthropathy (99.0%)
- osteomyelitis (disease) (99.0%)
- IgG4-related sclerosing cholangitis (99.0%)
- staphylococcal pneumonia (99.0%)
- cholangitis (99.0%)
- paratyphoid fever (99.8%)
- diffuse scleroderma (99.8%)
- punctate epithelial keratoconjunctivitis (99.8%)
- typhoid fever (99.8%)
- epiglottitis (99.7%)
- salmonellosis (99.7%)
- congenital analbuminemia (99.6%)
- polyclonal hyperviscosity syndrome (99.6%)
- hyperamylasemia (99.6%)
- meningococcemia (99.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.